Introducing Gluetacs Therapeutics to the UK market
Gluetacs Therapeutics (www.gluetacs.com), a pioneering biotech company located in the innovative Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, is making significant strides in the field of targeted protein degradation, both in molecular glue (GLUE) and bifunctional degrader (GLUETAC). As a member of the Lingang Cambridge Network, Gluetacs is committed to advancing its cutting…
Cambridge Independent Business Awards 2024
We are thrilled to announce that Costello Medical won two prestigious awards at the inaugural Cambridge Independent Business Awards 2024! Congratulations to all the winners and finalists from the other categories and a big thank you to the Cambridge Independent for putting on such a wonderful gala at King’s College, Cambridge to celebrate the Cambridge business community’s successes!
FUJIFILM Irvine Scientific Adds Key Products To Its Life Sciences Portfolio From FUJIFILM Wako Chemicals U.S.A.
Additional products in lab automation, lab chemicals and LAL expand complete solutions available directly from FUJIFILM Irvine Scientific to customers in US and Europe Sales agreement aligns business and commercial operations to maximize customer benefit
Bus franchising consultation reaches half way mark
The Cambridgeshire and Peterborough Combined Authority’s bus franchising consultation is reaching its halfway mark.
Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions
Axxam S.p.A. and Isogenica Ltd. have announced a partnership to bring together functional bioassay capabilities with unique antibody discovery solutions for biotechnology and pharmaceutical clients.
Why climate change investment pays off
Cost of inaction on climate change far outweighs the cost of proactive investment, says new analysis issued at New York Climate Week.
Hospital prosthetics service moves to high-tech new home
An Addenbrooke’s service that offers vital support for amputees and others officially opened on the 23rd Sept at a high-tech new home after nearly quarter of a century at the hospital.
Have a heart – learn CPR, says MP
In advance of World Heart Day, Daniel Zeichner, Member of Parliament for Cambridge, tried out RevivR, a new CPR training tool, at a British Heart Foundation (BHF) shop in Cambridge on Friday 20 September to highlight the charity's vital work in combating heart and circulatory diseases.
V&A Illustration Awards recognise Aditi’s talents
Recent Anglia Ruskin University graduate is named Emerging Illustrator of 2024.
Rail Gourmet uses Timestip multi-use indicators for enhanced food safety
Food waste reduced by a half.
impulse’s next-gen female entrepreneurs eye up $1trillion FemTech sector
With the FemTech market set to be worth $1trillion by 2027 (McKinsey & Company), impulse, the University of Cambridge’s unique entrepreneurship programme, has seen a sharp rise in the number of participants contributing novel innovations to this exciting sector.
Transforming healthcare: the power of purpose-led partnerships
In this episode, Dr Bipin Patel sits down with Samuel Hollis, Coun
Enterprise Therapeutics granted ‘rare pediatric disease designation’ in the US for novel cystic fibrosis investigational therapy ETD001
ETD001 is a novel, first in class blocker of the epithelial sodium channel (ENaC) aimed at treating people with cystic fibrosis without current effective therapies ETD001 commenced Phase 2 clinical trials in July 2024, expected to complete in 2025
Wake up and smell the coffee on Fairtrade, urges Cambridge MP
To mark Fairtrade Fortnight, Daniel Zeichner, Member of Parliament for Cambridge, visited Café Abantu on Friday 20 September 2024 to highlight its dedication to Fairtrade and sustainable practices.
Nxera Pharma receives approval of QUVIVIQ (daridorexant) in Japan for the treatment of insomnia
The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 trial in Japan that met all primary and secondary endpoints Plans to make QUVIVIQ available as soon as possible to insomnia patients in Japan are underway Tokyo, Japan and Cambridge, UK, 24 September 2024 – Nxera Pharma Co., Ltd. – formerly known as…
Benefits of District Council’s cost-of-living support highlighted
The latest cost-of-living support that has benefited thousands of South Cambridgeshire residents has been outlined in a new District Council report.
Art exhibition to raise awareness of domestic abuse
ARU to display work produced by survivors to mark Domestic Abuse Awareness Month.
Takeda’s Qdenga® - more campaigns needed before single-dose products arrive
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the dengue endemic vaccines market.
Professor to lead new £11.3m research centre
Emma Williams will lead ARU centre working with uniformed public services.
Cambridge Index falls 1.5%
The Cambridge Index dropped 312.22 points or 1.5% to close at 20,013.5, as five out of the top ten index heavyweights posted weekly losses in their share price.
PA Consulting appoints Henrik Ringgaard Pedersen as new Head of Nordics
PA Consulting, the global innovation and transformation consultancy, has named Henrik Ringgaard Pedersen as its new Head of Nordics, reinforcing the company’s strategic position as a key innovation and transformation partner for both private and public sector organisations in the region.
Most new recessive developmental disorder diagnoses lie within known genes
Researchers assessed the role of recessive genetic variants in developmental disorders, suggesting reanalysis of genetic data could improve understanding and diagnosis of conditions for millions of families worldwide.
Johnson Matthey announces Nature Strategy
Johnson Matthey announces its new Nature Strategy, outlining the company’s commitments and actions to minimise its environmental footprint, promote circularity, and enhance the local environments and communities where it operates. The strategy sets ambitious goals for the responsible use of natural resources and reinforces JM’s commitment to restoring biodiversity.
KKR completes acquisition of geospatial software business IQGeo
London, 24 September 2024 – KKR, a leading global investment firm, announces the completion of its acquisition of IQGeo, a geospatial software developer headquartered in the U.K.